相关实验视频

Updated: Apr 29, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

在患有多发性硬化症的人群中感知到双重任务困难的患病率和规模:一项国际研究

Zuhal Abasıyanık¹, Ludovico Pedullà², Turhan Kahraman³

¹REVAL Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Hasselt, Belgium; Universitair MS Centrum (UMSC), Hasselt-Pelt, Belgium; Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Katip Celebi University, Izmir, Turkey.

Archives of physical medicine and rehabilitation

|September 8, 2025

概括

双重任务困难在患有多发性硬化症 (MS) 的人群中很普遍,随着残疾的严重程度而增加. 像DIDA-Q这样的问卷有效地识别出这些临床使用的挑战.

科学领域:

神经学神经学
康复科学康复科学康复科学
心理测量心理测量心理测量

背景情况:

双重任务 (DT) 困难在患有多发性硬化症 (pwMS) 的人中很常见.
评估感知到的DT困难对于理解功能限制至关重要.

研究的目的:

确定pwMS中DT困难的流行率和严重程度.
评估三个问卷 (DTQ,DTSL,DIDA-Q) 在识别这些困难时的辨别能力.

主要方法:

一个多中心的,横截面研究,涉及540名参与者 (pwMS轻度/中度至重度残疾和对照).
对于DTQ,DTSL和DIDA-Q计算了流行率,效果大小 (ES) 和接收器运行特征曲线 (AUC) 下的面积.
截止分数是根据没有MS的个体的分数建立的.

主要成果:

25%-45%的轻度残疾pwMS和49%-87%的中度至重度残疾pwMS报告了DT困难.
这三个问卷都显示了中度至大度的辨别能力 (ES:0.61-0.80).
与DTSL (0.866) 和DTQ (0.802) 相比,DIDA-Q显示了最高的区分能力 (AUC:0.904).

结论:

在pwMS中,感知到的DT困难是显著的,并且随着残疾而升级.
DTQ,DTSL和DIDA-Q是有效的工具,用于识别pwMS中的DT困难.
在这个人群中,DIDA-Q表现出优越的判别能力来评估DT挑战.

关键词:

认知 - 运动干扰这是一个双重任务.多发性硬化症是一种多发性硬化症.在这种情况下,Prom是Prom.问卷调查问卷问卷调查问卷康复康复康复康复有效性有效性是有效性的.

更多相关视频

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Revised and Neuroimaging-Compatible Versions of the Dual Task Screen

Published on: October 5, 2020

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...